Investment Analysts’ Weekly Ratings Updates for Omada Health (OMDA)

A number of research firms have changed their ratings and price targets for Omada Health (NASDAQ: OMDA):

• 3/6/2026 – Omada Health had its price target lowered by Canaccord Genuity Group Inc. from $28.00 to $22.00. They now have a “buy” rating on the stock.
• 3/6/2026 – Omada Health had its price target lowered by BMO Capital Markets from $27.00 to $18.00. They now have an “outperform” rating on the stock.
• 3/6/2026 – Omada Health had its price target lowered by Morgan Stanley from $32.00 to $30.00. They now have an “overweight” rating on the stock.
• 3/3/2026 – Omada Health had its price target lowered by Barclays PLC from $22.00 to $17.00. They now have an “overweight” rating on the stock.
• 1/22/2026 – Omada Health had its “sell (d)” rating reaffirmed by Weiss Ratings.
• 1/22/2026 – Omada Health had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $28.00 price target on the stock.
• 1/16/2026 – Omada Health had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $26.00 price target on the stock.
• 1/9/2026 – Omada Health was given a new $29.00 price target by The Goldman Sachs Group, Inc..
• 1/8/2026 – Omada Health is now covered by Wells Fargo & Company. They set an “equal weight” rating and a $17.00 price target on the stock.
• 1/8/2026 – Omada Health was upgraded by Wells Fargo & Company to “hold”.

Insider Buying and Selling

In other news, CEO Sean P. Duffy sold 230,479 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $15.60, for a total transaction of $3,595,472.40. Following the transaction, the chief executive officer directly owned 126,644 shares of the company’s stock, valued at approximately $1,975,646.40. The trade was a 64.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Wei-Li Shao sold 5,618 shares of the business’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $16.13, for a total value of $90,618.34. Following the transaction, the president directly owned 69,079 shares in the company, valued at $1,114,244.27. This trade represents a 7.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 276,893 shares of company stock valued at $4,336,787 in the last ninety days.

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.